Evercore ISI raised the firm’s price target on Humana (HUM) to $195 from $180 and keeps an In Line rating on the shares. The firm made several price target adjustments and additions to the firm’s Tactical call lists as part of the firm’s healthcare technology and distribution preview for Q1.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HUM:
- Humana Health Horizons in Ohio, CPESN launch Pharmacist Quality Rewards program
- Humana price target lowered to $258 from $310 at Mizuho
- UnitedHealth (UNH) vs. Humana (HUM): Which Healthcare Stock Is the Better Bet After the CMS Update?
- Midday Fly By: Health insurers get ‘positive surprise’ from CMS
- Early notable gainers among liquid option names on April 7th